Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma. (7th November 2013)
- Record Type:
- Journal Article
- Title:
- Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma. (7th November 2013)
- Main Title:
- Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma
- Authors:
- Sabado, Rachel L
Pavlick, Anna
Gnjatic, Sacha
Cruz, Crystal
Vengco, Isabelita
Hasan, Farah
Darvishian, Farbod
Chiriboga, Luis
Holman, Rose Marie
Escalon, Juliet
Muren, Caroline
Escano, Crystal
Yepes, Ethel
Sharpe, Dunbar
Adams, Sylvia
Ott, Patrick
Jungbluth, Achim
Pan, Linda
Venhaus, Ralph
Bhardwaj, Nina - Abstract:
- Is Part Of:
- Journal for immunotherapy of cancer. Volume 1(2013)Supplement 1
- Journal:
- Journal for immunotherapy of cancer
- Issue:
- Volume 1(2013)Supplement 1
- Issue Display:
- Volume 1, Issue 1 (2013)
- Year:
- 2013
- Volume:
- 1
- Issue:
- 1
- Issue Sort Value:
- 2013-0001-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2013-11-07
- Subjects:
- Melanoma -- Melanoma Patient -- Topical Application -- Cellular Immune Response -- Cancer Vaccine
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105 - Journal URLs:
- http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/2051-1426-1-S1-P272 ↗
- Languages:
- English
- ISSNs:
- 2051-1426
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19215.xml